Hill-Rom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Hill-Rom and buy or sell other stocks, ETFs, and their options commission-free!

About HRC

Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. 

CEO
John P. Groetelaars, MBA
CEOJohn P. Groetelaars, MBA
Employees
Employees
Headquarters
Chicago, Illinois
HeadquartersChicago, Illinois
Founded
1915
Founded1915
Employees
Employees

HRC Key Statistics

Market cap
10.30B
Market cap10.30B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
288.14K
Average volume288.14K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$156.22
52 Week high$156.22
52 Week low
$93.34
52 Week low$93.34

Stock Snapshot

Hill-Rom(HRC) stock is priced at $155.96, giving the company a market capitalization of 10.3B.

On 2026-03-09, Hill-Rom(HRC) stock opened at —, reached a high of —, and a low of —.

The Hill-Rom(HRC)'s current trading volume is 0, compared to an average daily volume of 288.14K.

In the last year, Hill-Rom(HRC) shares hit a 52-week high of $156.22 and a 52-week low of $93.34.

In the last year, Hill-Rom(HRC) shares hit a 52-week high of $156.22 and a 52-week low of $93.34.

People also own

Based on the portfolios of people who own HRC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.